4.6 Article

The fatty acid elongase ELOVL6 regulates bortezomib resistance in multiple myeloma

期刊

BLOOD ADVANCES
卷 5, 期 7, 页码 1933-1946

出版社

ELSEVIER
DOI: 10.1182/bloodadvances.2020002578

关键词

-

资金

  1. National Institutes of Health, National Cancer Institute [CA193981, CA224434, CA190533]
  2. International Myeloma Foundation Brian D. Novis Senior Research Grant Award
  3. Wake Forest Baptist Comprehensive Cancer Center Proteomics and Metabolomics Shared Resource
  4. National Cancer Institute Cancer Center Support grant [P30CA012197]

向作者/读者索取更多资源

This study identified the role of lipid metabolism in the resistance of multiple myeloma cells to the proteasome inhibitor bortezomib. Lower levels of fatty acid elongase 6 (ELOVL6) were found in bortezomib-nonresponsive MM cells compared to bortezomib-responsive cells. Restoring ELOVL6 levels resensitized resistant cells by upregulating ceramide species, essential for bortezomib-induced endoplasmic reticulum stress and cell death.
Resistance to the proteasome inhibitor bortezomib (BTZ) represents a major obstacle in the treatment of multiple myeloma (MM). The contribution of lipid metabolism in the resistance of MM cells to BTZ is mostly unknown. Here we report that levels of fatty acid elongase 6 (ELOVL6) were lower in MM cells from BTZ-nonresponsive vs BTZ-responsive patients and in cultured MM cells selected for BTZ resistance compared with parental counterparts. Accordingly, depletion of ELOVL6 in parental MM cells suppressed BTZ-induced endoplasmic reticulum (ER) stress and cytotoxicity, whereas restoration of ELOVL6 levels in BTZ-resistant MM cells sensitized them to BTZ in tissue culture settings and, as xenografts, in a plasmacytoma mouse model. Furthermore, for the first time, we identified changes in the BTZ-induced lipidome between parental and BTZ-resistant MM cell lines underlying a. a functional difference in their response to BTZ. We demonstrated that restoration of ELOVL6 levels in BTZ-resistant MM cells resensitized them to BTZ largely via upregulation of ELOVL6-dependent ceramide species, which was a prerequisite for BTZ-induced ER stress and cell death in these cells. Our data characterize ELOVL6 as a major clinically relevant regulator of MM cell resistance to BTZ, which can emerge from the impaired ability of these cells to alter ceramide composition in response to BTZ.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据